Payment overview · 2025
General Payments
$306.55
7 reported records · 2 companies
Healthcare provider profile · identity verified
Danny Joseph Sayegh, MD
Allopathic & Osteopathic Physicians|Family Medicine · LAS VEGAS, NV · NPI 1487090981
Verified facts
What the public records show
CMS Open Payments records show Danny Joseph Sayegh, MD received $306.55 in general payments during 2025 across 7 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 53.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $163.79 | 53.4% | 6 | 2025 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | Unresolved — no canonical attribution shown | $142.76 | 46.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $306.55 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc., Otsuka Pharmaceutical Development & Commercialization, Inc. | $306.55 | 7 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 624 | 132 |
| Sertraline Hcl | Sertraline Hcl | 572 | 108 |
| Furosemide | Furosemide | 553 | 115 |
| Levothyroxine Sodium | Levothyroxine Sodium | 545 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 521 | 118 |
| Donepezil Hcl | Donepezil Hcl | 491 | 102 |
| Mirtazapine | Mirtazapine | 466 | 87 |
| Quetiapine Fumarate | Quetiapine Fumarate | 408 | 103 |
| Potassium Chloride | Potassium Chloride | 391 | 89 |
| Risperidone | Risperidone | 379 | 78 |
| Lisinopril | Lisinopril | 370 | 78 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 290 | 181 |
| Eliquis | Apixaban | 274 | 53 |
| Memantine Hcl | Memantine Hcl | 251 | 49 |
| Gabapentin | Gabapentin | 247 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 244 | 57 |
| Losartan Potassium | Losartan Potassium | 219 | 53 |
| Trazodone Hcl | Trazodone Hcl | 217 | 39 |
| Metformin Hcl | Metformin Hcl | 216 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 206 | 43 |
| Naproxen | Naproxen | 173 | 68 |
| Escitalopram Oxalate | Escitalopram Oxalate | 161 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 43 |
| Famotidine | Famotidine | 151 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 150 | 37 |
| Prednisone | Prednisone | 145 | 60 |
| Metoprolol Succinate | Metoprolol Succinate | 137 | 31 |
| Carvedilol | Carvedilol | 135 | 32 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 128 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 127 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 123 | 29 |
| Divalproex Sodium | Divalproex Sodium | 123 | 22 |
| Levofloxacin | Levofloxacin | 119 | 82 |
| Omeprazole | Omeprazole | 114 | 26 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 101 | 23 |
| Pregabalin | Pregabalin | 96 | 15 |
| Alendronate Sodium | Alendronate Sodium | 93 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 89 | 74 |
| Farxiga | Dapagliflozin Propanediol | 88 | 21 |
| Loperamide | Loperamide Hcl | 84 | 51 |
| Jardiance | Empagliflozin | 83 | 19 |
| Montelukast Sodium | Montelukast Sodium | 80 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 78 | 64 |
| Ondansetron Hcl | Ondansetron Hcl | 77 | 65 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 76 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 76 | 17 |
| Methenamine Hippurate | Methenamine Hippurate | 75 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 75 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 72 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 71 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 33 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 68 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 67 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 66 | 16 |
| Megestrol Acetate | Megestrol Acetate | 65 | 28 |
| Oxycodone Hcl | Oxycodone Hcl | 65 | 14 |
| Ibuprofen | Ibuprofen | 64 | 25 |
| Morphine Sulfate Er | Morphine Sulfate | 63 | 11 |
| Allopurinol | Allopurinol | 62 | 12 |
| Fluconazole | Fluconazole | 62 | 44 |
| Januvia | Sitagliptin Phosphate | 62 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 62 | 55 |
| Lorazepam | Lorazepam | 60 | 24 |
| Amiodarone Hcl | Amiodarone Hcl | 59 | 14 |
| Finasteride | Finasteride | 59 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 57 | 21 |
| Aripiprazole | Aripiprazole | 55 | suppressed |
| Ondansetron Odt | Ondansetron | 55 | 23 |
| Simvastatin | Simvastatin | 54 | 14 |
| Memantine Hcl Er | Memantine Hcl | 53 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 51 | suppressed |
| Chlorthalidone | Chlorthalidone | 50 | suppressed |
| Spironolactone | Spironolactone | 50 | 14 |
| Levetiracetam | Levetiracetam | 47 | suppressed |
| Baclofen | Baclofen | 45 | 11 |
| Latanoprost | Latanoprost | 45 | 11 |
| Xarelto | Rivaroxaban | 45 | 13 |
| Midodrine Hcl | Midodrine Hcl | 43 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Atenolol | Atenolol | 41 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 40 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | 16 |
| Ozempic | Semaglutide | 39 | suppressed |
| Haloperidol | Haloperidol | 38 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 37 | 13 |
| Propranolol Hcl | Propranolol Hcl | 37 | suppressed |
| Galantamine Er | Galantamine Hbr | 36 | suppressed |
| Glipizide | Glipizide | 36 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 36 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 35 | suppressed |
| Clonazepam | Clonazepam | 34 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 33 | 19 |
| Ezetimibe | Ezetimibe | 33 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | 14 |
| Klor-Con M20 | Potassium Chloride | 32 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 31 | suppressed |
| Primidone | Primidone | 31 | suppressed |
| Ramipril | Ramipril | 31 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 31 | suppressed |
| Lamotrigine | Lamotrigine | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Folic Acid | Folic Acid | 28 | suppressed |
| Olanzapine | Olanzapine | 28 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Temazepam | Temazepam | 27 | suppressed |
| Amantadine | Amantadine Hcl | 26 | suppressed |
| Alprazolam | Alprazolam | 25 | 12 |
| Sucralfate | Sucralfate | 25 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 25 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Repaglinide | Repaglinide | 23 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 22 | suppressed |
| Myrbetriq | Mirabegron | 22 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 22 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 15 |
| Oxcarbazepine | Oxcarbazepine | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 19 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 19 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Isoniazid | Isoniazid | 18 | suppressed |
| Lactulose | Lactulose | 18 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | 11 |
| Azithromycin | Azithromycin | 16 | 14 |
| Meloxicam | Meloxicam | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | 12 |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Neupro | Rotigotine | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 14 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 12 | suppressed |
| Exelon | Rivastigmine | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | 11 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Linezolid | Linezolid | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $306.55 · 7 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error